跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,122 条关于
“Formosa Pharmaceuticals”
全部
10,122
临床试验
1,692
药物
1,740
机构
2,046
资讯
4,644
去年
Formosa Pharma's CPN-303 (APP13007) Achieves Positive Phase 3 Results in China for Post-Cataract Surgery Inflammation and Pain
4个月前
Formosa Pharmaceuticals Partners with Singapore Eye Research Institute to Develop Advanced Ophthalmic Formulations
去年
Formosa Pharmaceuticals and Cipla Form Strategic Partnership for APP13007 Commercialization Across 11 Countries
去年
Taiwan's Formosa Pharmaceuticals Signs Exclusive Licensing Deal with Almac Discovery for ADC Development
去年
Formosa Pharmaceuticals Secures Exclusive License for Novel Bispecific ADC Targeting EGFR/ROR1 Solid Tumors
9个月前
Formosa Pharmaceuticals Expands Global Reach of FDA-Approved Eye Surgery Treatment Through ASEAN Partnership
16天前
Formosa Pharmaceuticals Targets First ADC Biosimilar Launch in US and Europe with TSY-110
21天前
Formosa Pharmaceuticals Files CTA for TSY-110, a First-in-Class ADC Biosimilar Targeting HER2-Positive Breast Cancer
2年前
Eyenovia and Formosa Pharma Launch FDA-Approved APP13007 for Postoperative Ocular Inflammation
去年
Eyenovia Launches Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain
第 1 页,共 465 页
上一页
下一页